About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

NCT00659607·326 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Boehringer Ingelheim

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

patients diagnosed with essential hypertension

You may not be if

patients who took Micardis Plus before participating in this PMS study

The record

StatusCompleted

PhaseNo phase

Taking part6,901

StartedSep 2003

UpdatedJun 6, 2014

Conditions

Where326

Boehringer Ingelheim Investigational Site 10
Busan, South Korea
Boehringer Ingelheim Investigational Site 11
Busan, South Korea
Boehringer Ingelheim Investigational Site 12
Busan, South Korea

Clareo Health | Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension